Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial.
Shoaib AshrafSohaib AshrafIqra FarooqSidra AshrafMoneeb AshrafMuhammad Ahmad ImranLarab KalsoomRutaba AkmalMuhammad GhufranSundas RafiqueMuhammad Kiwan AkramZaigham HabibUzma Nasim SiddiquiAmmara AhmadShahroze ArshadMuhammad Abdul Rehman VirkMehak GulAbeer Bin AwaisMuhammad HassanSyed Sami Hussain SheraziZartasha SafdarIsra MunirHamna KhalidKhalid MunirNighat MajeedYaser Masuod AlahmadiAyesha HumayunQazi Abdul SaboorAli AhmadMuhammad AshrafMateen Izharnull nullPublished in: Trials (2021)
The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). With the intention of expediting dissemination of this trial, the conventional formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol. The study protocol has been reported in accordance with the Standard Protocol Items: Recommendations for Clinical Interventional Trials (SPIRIT) guidelines.